Meta-analysis
Year of publication
Number of patients
Number of studies
OR (CI 95 %)
OR (CI 95 %)
OR (CI 95 %)
–
–
–
–
Aprotinin versus tranexamic acid
Aprotinin versus aminocaproic acid
Aprotinin versus placebo
Howell [12]abc
2013
15,528
88
0.73 (0.45–1.12)
0.88 (0.50–2.13)
1.11 (0.75-1.53)
Hutton [14]ac
2012
14,773
82
0.64 (0.41–0.99)
0.79 (0.47–1.55)
0.99 (0.72–1.36)
Hutton [14]abc
2012
41,350
93
0.71 (0.50–0.98)
0.60 (0.43–0.87)
0.91 (0.71–1.16)
Henry [13]ad
2011
17,136
85
1.35 (0.94–1.93)
1.51 (0.99–2.30)
0.81 (0.63–1.06)
Table 16.2
Meta-analyses of aprotinin-related studies—mortality and number of patients
Meta-analysis | Number of patients | Number of studies | Number of patients/deaths (%) | RR 95 % CI | |||
|---|---|---|---|---|---|---|---|
– | – | – | Aprotinin | TXA | EACA | Control | – |
Howell [12]abc | 15,528 | 88 | 6,284/177 (2.81 %) | 3,048/62 (2.03 %) | 1,309/44 (3.36 %) | 4,887/110 (2.25 %) | NS |
Henry [13]d (cochrane): | – | – | – | – | – | – | – |
A versus control | 8,876 | 63 | 4,889/116 (2.37 %) | – | – | 3,987/104 (2.6 %) | 0.81 (0.63 to 1.06) |
TXA versus Control | 2,917 | 30 | – | 1,478/15 (1.01 %) | – | 1,439/28 (1.94 %) | 0.60 (0.33–1.10) |
EACA versus Control | 922 | 8 | – | – | 504/10 (1.98 %)
Related posts: The Risks and Benefits of the Consensus Process
Can Neuraxial Anesthesia Reduce Perioperative Mortality?
Role of Inhalational Anesthetic Agents in Reducing Perioperative Mortality
Leukocyte Depletion of Transfused Blood to Reduce Perioperative Mortality
Consensus Conference on Perioperative Mortality: An Update
 The Process of Consensus Building
Full access? Get Clinical Tree
Get Clinical Tree app for offline access
| ||